GO:0030975 thiamine binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030975 (thiamine binding) is a molecular function describing the selective, non-covalent interaction of a protein or RNA with thiamine (vitamin B1), a water-soluble vitamin essential for carbohydrate metabolism and neural function.
• Thiamine-binding proteins include thiamine transporters, thiamine pyrophosphate (TPP) riboswitches, and TPP-dependent enzymes; their binding defects are linked to conditions such as thiamine-responsive megaloblastic anemia and TPK deficiency disorder.
• Reduced thiamine binding by thiamine pyrophosphokinase (TPK) is a novel disease mechanism in TPK deficiency disorder, highlighting the clinical relevance of this GO term.
• Thiamine binding is a validated target for antimicrobial and herbicide discovery, as shown by inhibitors of thiamine thiazole synthase in Botrytis cinerea and thiamine uptake inhibitors.
• Gold complexes and other metal-based compounds can modulate TPP-dependent enzymes by interacting with thiamine-binding sites, offering a route to enzyme inhibition.
• CRISPR-based knockout, point-mutation, and knock-in models enable precise dissection of thiamine-binding proteins in human cells and model organisms, accelerating target validation.
Description
Thiamine (vitamin B1) is an essential micronutrient that serves as a precursor to thiamine pyrophosphate (TPP), a cofactor for key enzymes in glycolysis, the pentose phosphate pathway, and branched-chain amino acid metabolism. The molecular function GO:0030975, thiamine binding, describes the ability of proteins and RNA elements to specifically recognize and bind thiamine. This function is fundamental to thiamine homeostasis, as it underlies transport, sensing, and cofactor delivery across all domains of life. Defects in thiamine-binding proteins cause human disorders such as thiamine-responsive megaloblastic anemia and TPK deficiency disorder, and thiamine-binding sites are emerging as drug targets in infectious diseases and cancer. Researchers study thiamine binding to understand how cells acquire and utilize vitamin B1, how riboswitches regulate gene expression in response to thiamine levels, and how pathogens and plants depend on thiamine-binding enzymes for survival. The binding event is often the first step in a cascade that controls metabolic flux and gene regulation. Because thiamine binding is a molecular function, it can be assayed directly using biochemical, structural, and genetic methods, and it can be disrupted or enhanced using CRISPR-based genome editing. This article provides a comprehensive overview of GO:0030975, covering its definition, biological significance, key genes, disease connections, and state-of-the-art research methods. It is intended for researchers, drug developers, and students who need a precise, citation-backed resource on thiamine binding.
thiamine binding At A Glance
| GO ID | GO:0030975 |
|---|---|
| GO term | thiamine binding |
| Ontology | molecular_function |
| Synonym | thiamin binding; vitamin B1 binding |
| Definition | Binding to thiamine (vitamin B1), a water soluble vitamin present in fresh vegetables and meats, especially liver. |
| Major function | Specific recognition and non-covalent interaction with thiamine, enabling transport, sensing, and cofactor delivery. |
| Representative proteins | Thiamine transporters (e.g., SLC19A2, SLC19A3), thiamine pyrophosphokinase (TPK1), TPP riboswitches, thiamine thiazole synthase (THI4). |
| Associated diseases | Thiamine-responsive megaloblastic anemia, TPK deficiency disorder, Wernicke-Korsakoff syndrome, beriberi. |
| Research methods | Isothermal titration calorimetry, surface plasmon resonance, X-ray crystallography, CRISPR knockout/knock-in, riboswitch assays. |
What Is GO:0030975?
GO:0030975 (thiamine binding) is defined by the Gene Ontology as the binding to thiamine (vitamin B1), a water-soluble vitamin present in fresh vegetables and meats, especially liver. In practice, this means any protein or RNA molecule that selectively interacts with thiamine via non-covalent forces, such as hydrogen bonding, electrostatic interactions, and aromatic stacking, without chemically modifying the ligand. This function is distinct from thiamine transport or thiamine metabolism, although binding is often a prerequisite for those processes. Thiamine-binding proteins include periplasmic binding proteins, thiamine transporters, TPP riboswitches, and enzymes that use TPP as a cofactor.
Why Is thiamine binding Important in Cell Biology?
Thiamine binding is a critical molecular function because it governs the bioavailability and cellular utilization of vitamin B1, a nutrient that cannot be synthesized by humans and must be obtained from the diet. Defects in thiamine-binding proteins lead to severe neurological and hematological disorders, and the binding event is a validated target for antibiotics, herbicides, and anticancer agents. Understanding thiamine binding at the molecular level informs drug design, nutritional science, and synthetic biology.
• Thiamine binding is essential for the transport of vitamin B1 across cell membranes, as mediated by SLC19A2 and SLC19A3.
• TPP riboswitches rely on thiamine binding to regulate gene expression in bacteria and plants, providing a model for RNA-ligand interactions.
• Reduced thiamine binding by TPK1 causes TPK deficiency disorder, a neurometabolic disease.
• Thiamine-binding proteins are targets for antifungal agents, as shown for Botrytis cinerea thiamine thiazole synthase.
• Inhibition of thiamine uptake is a potential strategy against pathogens and cancer cells.
• Gold complexes can interact with thiamine-binding sites in TPP-dependent enzymes, expanding the scope of metal-based drugs.
• Thiamine-binding assays are used for vitamin B1 quantification in food and clinical samples.
• Thiamine-binding proteins are involved in neurodegeneration, including Wernicke-Korsakoff syndrome.
• CRISPR screens can identify genes required for thiamine binding and uptake, linking genotype to phenotype.
• Thiamine binding is a paradigm for understanding molecular recognition of small, polar ligands by proteins and RNA.
Molecular Mechanism of thiamine binding
Substrate recognition and binding pocket architecture
In simple terms: Proteins that bind thiamine have a pocket that fits the vitamin like a lock and key.
Thiamine-binding proteins typically possess a defined binding pocket lined with polar and aromatic residues that form hydrogen bonds and π-stacking interactions with the pyrimidine and thiazolium rings of thiamine. For example, the TPP riboswitch uses π-stacking interactions to achieve high-affinity ligand binding, as revealed by quantum chemical calculations and docking studies. Periplasmic binding proteins from bacteria also exhibit high specificity for thiamine, enabling its isolation from complex matrices.
Conformational changes upon thiamine binding
In simple terms: When thiamine binds, the protein or RNA often changes shape to lock it in place.
Binding of thiamine can induce conformational changes in the receptor, as seen in periplasmic binding proteins that undergo a Venus flytrap-like closure. In TPP riboswitches, ligand binding stabilizes a specific RNA fold that modulates transcription termination or translation initiation. These structural rearrangements are critical for signal transduction and transport.
Cofactor and metal ion interactions
In simple terms: Some thiamine-binding proteins use metals or other cofactors to help bind thiamine.
Gold complexes can bind to thiamine diphosphate-dependent enzymes, interacting with the thiamine-binding site and inhibiting catalysis. This suggests that metal ions or metal-based drugs can modulate thiamine binding. Additionally, magnesium ions are often required for TPP riboswitch folding and ligand recognition.
Regulation of thiamine binding by cellular signals
In simple terms: Cells can adjust how much thiamine they bind based on need.
Thiamine binding by riboswitches is regulated by intracellular thiamine pyrophosphate levels, which reflect thiamine availability. In humans, thiamine transporters are regulated by thiamine status and may be affected by mutations that alter binding affinity. This feedback ensures thiamine homeostasis.
Inhibition and pharmacological modulation
In simple terms: Drugs can block thiamine binding to treat infections or cancer.
Structure-based discovery has identified small molecules that inhibit thiamine uptake by targeting thiamine-binding proteins. Similarly, neocryptolepine derivatives inhibit Botrytis cinerea by targeting thiamine thiazole synthase, which binds thiamine. These examples highlight the druggability of thiamine-binding sites.
Key Genes Involved in GO:0030975 thiamine binding
The following genes encode proteins or RNA elements that directly bind thiamine or are involved in thiamine-binding-dependent processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC19A2 | Thiamine transporter 1 (THTR1) | Mutations cause thiamine-responsive megaloblastic anemia; target for CRISPR knockout to study transport. |
| SLC19A3 | Thiamine transporter 2 (THTR2) | Defects linked to biotin-responsive basal ganglia disease; used in uptake assays. |
| TPK1 | Thiamine pyrophosphokinase | Reduced thiamine binding causes TPK deficiency disorder; model for point mutations. |
| THI4 | Thiamine thiazole synthase | Target of antifungal neocryptolepine derivatives; binds thiamine. |
| thiM | Hydroxyethylthiazole kinase (bacterial) | Part of thiamine biosynthesis; potential antibiotic target. |
| thiC | Phosphomethylpyrimidine synthase | Involved in thiamine synthesis; not a direct binder but pathway component. |
| TPP riboswitch (thiC leader) | RNA element that binds TPP | Model for RNA-ligand interactions; studied via docking and mutagenesis. |
| PDH (pyruvate dehydrogenase) | TPP-dependent enzyme | Binds TPP; inhibited by gold complexes. |
| OGDH (2-oxoglutarate dehydrogenase) | TPP-dependent enzyme | Binds TPP; target for metabolic studies. |
| BCKDH (branched-chain ketoacid dehydrogenase) | TPP-dependent enzyme | Binds TPP; relevant to maple syrup urine disease. |
| Transketolase (TKT) | TPP-dependent enzyme | Binds TPP; involved in pentose phosphate pathway. |
| Thiamine-binding periplasmic protein (tbpA) | Bacterial thiamine uptake | Used for magnetic isolation of thiamine. |
| SLC19A1 | Reduced folate carrier | Can transport thiamine analogs; not a primary binder. |
| SLC22A1 | Organic cation transporter | May transport thiamine; indirect role. |
| THTR1 (SLC19A2) variants | Mutant transporters | Studied via knock-in to assess binding defects. |
| TPK1 mutants | Impaired thiamine binding | Modeled in patient cells and CRISPR-edited lines. |
How Is thiamine binding Regulated?
Thiamine binding is regulated at multiple levels. In bacteria and plants, TPP riboswitches directly sense thiamine pyrophosphate and control gene expression through ligand-dependent conformational changes. In humans, thiamine transporters are regulated by thiamine availability, and mutations in SLC19A2 or TPK1 can alter binding affinity and protein stability. Additionally, post-translational modifications and interacting proteins may modulate thiamine-binding activity, though specific mechanisms remain to be fully elucidated. The mTOR pathway has not been directly linked to thiamine binding in the provided literature.
thiamine binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TPK1 | TPK deficiency disorder | Knock-in of patient mutations in HEK293 or iPSCs; thiamine binding assay. |
| SLC19A2 | Thiamine-responsive megaloblastic anemia | CRISPR knockout in K562 or patient fibroblasts; transport assays. |
| SLC19A3 | Biotin-responsive basal ganglia disease | Knockout in neuronal cell lines; thiamine uptake measurements. |
| THI4 | Fungal infection (Botrytis cinerea) | Knockout in fungal strains; antifungal susceptibility testing. |
| TPP riboswitch | Bacterial gene regulation | In vitro transcription with mutant riboswitches; ligand binding assays. |
TPK deficiency disorder
Reduced thiamine binding by thiamine pyrophosphokinase (TPK1) is a novel mechanism for TPK deficiency disorder, an autosomal recessive neurometabolic disease characterized by developmental delay, seizures, and lactic acidosis. Mutations in TPK1 that impair thiamine binding lead to decreased TPP synthesis and subsequent metabolic failure. This highlights the clinical importance of precise thiamine-binding assays.
Thiamine-responsive megaloblastic anemia
Mutations in the thiamine transporter SLC19A2 cause thiamine-responsive megaloblastic anemia (TRMA), a rare disorder featuring diabetes mellitus, sensorineural deafness, and megaloblastic anemia. Defective thiamine binding and transport underlie the disease, and high-dose thiamine supplementation can partially rescue symptoms. CRISPR models of SLC19A2 mutations are valuable for testing binding-defective variants.
Neurodegeneration and Wernicke-Korsakoff syndrome
Thiamine deficiency leads to Wernicke-Korsakoff syndrome, a neurological disorder characterized by confusion, ataxia, and memory loss. Thiamine-binding proteins in the brain are critical for maintaining thiamine homeostasis, and their dysfunction may contribute to neurodegeneration. Research into thiamine binding could inform therapeutic strategies for these conditions.
Infectious disease targets
Thiamine-binding enzymes in pathogens are attractive drug targets. For example, the antifungal neocryptolepine derivative inhibits Botrytis cinerea by targeting thiamine thiazole synthase. Similarly, thiamine uptake inhibitors show promise against bacterial and fungal infections. These findings underscore the potential of thiamine-binding proteins as antimicrobial targets.
From thiamine binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC19A2 abolish thiamine uptake? | CRISPR knockout in HeLa or HEK293 cells. |
| Do TPK1 patient mutations impair thiamine binding? | Point mutation knock-in in HEK293 cells. |
| Can a tagged thiamine-binding protein be used for localization? | Knock-in of GFP or HA tag at endogenous locus. |
| Does overexpression of THI4 increase thiamine synthesis? | Overexpression in fungal or plant cells. |
| Which genes are essential for thiamine binding? | Genome-wide CRISPR library screening. |
| How does a riboswitch mutation affect gene regulation? | Knock-in of mutant riboswitch in bacterial genome. |
How to Study the thiamine binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry (ITC) | Binding affinity (Kd), stoichiometry, enthalpy | Characterize thiamine binding to purified proteins. |
| Surface plasmon resonance (SPR) | Kinetics (kon, koff) and affinity | Screen mutants for altered thiamine binding. |
| X-ray crystallography | 3D structure of protein-ligand complex | Define thiamine-binding pocket. |
| CRISPR knockout | Loss-of-function phenotype | Test if gene is required for thiamine uptake. |
| CRISPR knock-in | Expression of mutant or tagged protein | Model patient mutations in TPK1. |
| Riboswitch reporter assay | Ligand-dependent gene expression | Study TPP riboswitch regulation. |
| Magnetic isolation with periplasmic binding protein | Thiamine concentration in complex matrices | Quantify vitamin B1 in food or blood. |
| Docking and quantum chemical calculations | Predicted binding poses and interaction energies | Analyze π-stacking in riboswitch. |
Biochemical binding assays
Isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) can measure the affinity and kinetics of thiamine binding to purified proteins or RNA. These methods provide quantitative dissociation constants and stoichiometry, essential for comparing wild-type and mutant proteins.
Structural biology
X-ray crystallography and cryo-EM reveal the atomic details of thiamine-binding pockets, as demonstrated for TPP riboswitches and periplasmic binding proteins. Computational docking and quantum chemical calculations further elucidate π-stacking interactions.
Genetic and CRISPR screens
CRISPR knockout and activation screens can identify genes required for thiamine binding and uptake. Point mutations can be introduced to mimic patient variants, and knock-in reporters can track binding in live cells.
Riboswitch and RNA-based assays
In vitro transcription and ligand-dependent gel shifts are used to study TPP riboswitch binding. These assays are amenable to high-throughput screening for small-molecule modulators.
How CRISPR Can Be Used to Study GO:0030975 thiamine binding
Knockout
CRISPR knockout of thiamine-binding genes such as SLC19A2 or TPK1 can abolish thiamine uptake or TPP synthesis, providing a clean background to test rescue constructs. Knockout cell lines are valuable for drug sensitivity assays and metabolic profiling.
Point Mutation
Introducing patient-specific point mutations (e.g., in TPK1) via CRISPR base editing or homology-directed repair allows precise assessment of how single amino acid changes affect thiamine binding affinity and protein stability. This is critical for genotype-phenotype correlations.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) or reporter genes at endogenous loci enables real-time tracking of thiamine-binding proteins in live cells. Knock-in of mutant alleles can also create disease models without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase levels of thiamine-binding proteins to study gain-of-function effects, such as enhanced thiamine uptake or altered metabolic flux. Overexpression models are useful for structural and biochemical studies requiring large amounts of protein.
How EDITGENE Supports thiamine binding Research
Researchers studying thiamine binding-related genes often need to determine whether a candidate gene is causally involved in thiamine transport, sensing, or metabolism. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models, enabling rigorous functional validation of thiamine-binding proteins.
Contact EDITGENE today to design your custom CRISPR model for thiamine binding research.
Frequently Asked Questions About thiamine binding
What is thiamine binding?
Thiamine binding (GO:0030975) is the molecular function of selectively interacting with thiamine (vitamin B1) through non-covalent forces, enabling transport, sensing, and cofactor delivery.
What genes are involved in thiamine binding?
Key genes include SLC19A2, SLC19A3, TPK1, THI4, and TPP riboswitch elements, as well as TPP-dependent enzymes like PDH and OGDH.
What diseases are linked to thiamine binding defects?
TPK deficiency disorder, thiamine-responsive megaloblastic anemia, Wernicke-Korsakoff syndrome, and beriberi are associated with impaired thiamine binding.
How is thiamine binding measured?
Common methods include isothermal titration calorimetry, surface plasmon resonance, X-ray crystallography, and riboswitch reporter assays.
What is the role of TPP riboswitch in thiamine binding?
The TPP riboswitch binds thiamine pyrophosphate to regulate gene expression in bacteria and plants, serving as a model for RNA-ligand interactions.
Can CRISPR be used to study thiamine binding?
Yes, CRISPR knockout, knock-in, and point mutation models enable precise dissection of thiamine-binding protein function and disease variants.
What is the clinical significance of thiamine binding?
It is critical for vitamin B1 homeostasis; defects cause neurological and hematological disorders, and binding sites are drug targets.
Which proteins bind thiamine in humans?
SLC19A2, SLC19A3, TPK1, and TPP-dependent enzymes such as pyruvate dehydrogenase and transketolase bind thiamine or its derivatives.
How does thiamine binding relate to vitamin B1 deficiency?
Impaired binding reduces cellular thiamine uptake and TPP synthesis, leading to deficiency symptoms like beriberi and Wernicke-Korsakoff syndrome.
What model systems are used to study thiamine binding?
Human cell lines (HEK293, HeLa), patient-derived cells, yeast, bacteria, and plants are used, often with CRISPR editing.
Conclusion
GO:0030975 thiamine binding is a fundamental molecular function that underpins vitamin B1 transport, sensing, and metabolism across all kingdoms of life. Its dysregulation causes severe human diseases, and its inhibition offers therapeutic opportunities against pathogens and cancer. Advances in CRISPR genome editing and biochemical assays are accelerating our understanding of thiamine-binding proteins and their roles in health and disease.
References
- 1. Zhao WB et al.. 2025. Indoloquinoline alkaloid neocryptolepine derivative inhibits Botrytis cinerea by targeting thiamine thiazole synthase.. Sci Adv 11(11):eadq5329 PMID: 40073123
- 2. Burgener S et al.. 2023. Binding Interactions and Inhibition Mechanisms of Gold Complexes in Thiamine Diphosphate-Dependent Enzymes.. Biochemistry 62(22):3303-3311 PMID: 37931174
- 3. Huang W et al.. 2019. Reduced thiamine binding is a novel mechanism for TPK deficiency disorder.. Mol Genet Genomics 294(2):409-416 PMID: 30483896
- 4. Rybina AA et al.. 1980. [Proteins specifically binding thiamine and their biological role].. Ukr Biokhim Zh (1978) 52(5):652-67 PMID: 6789521
- 5. Edwards KA et al.. 2019. Periplasmic binding protein-based magnetic isolation and detection of thiamine in complex biological matrices.. Talanta 205:120168 PMID: 31450459
- 6. Gabriel F et al.. 2025. Structure-based discovery of thiamine uptake inhibitors.. Br J Pharmacol 182(22):5611-5626 PMID: 40702645
- 7. Itokawa Y et al.. 1982. Thiamin-binding proteins.. Ann N Y Acad Sci 378:327-36 PMID: 7044227
- 8. Wakchaure PD et al.. 2022. Unraveling the Role of π-Stacking Interactions in Ligand Binding to the Thiamine Pyrophosphate Riboswitch with High-level Quantum Chemical Calculations and Docking Study.. J Phys Chem B 126(5):1076-1084 PMID: 35089046
